Results 141 to 150 of about 889,079 (196)
Role of four new blood coagulation tests in cancer stem cell-mediated tumor-related venous thromboembolism. [PDF]
BioimpactsZhou N, Chen S.
europepmc +1 more source
Statistical optimization of fermentation conditions for enhanced production of Nattokinase from Bacillus subtilis MM26. [PDF]
BMC BiotechnolManeesha M, Subathra Devi C.
europepmc +1 more source
Some of the next articles are maybe not open access.
Related searches:
Related searches:
Fibrinolytic Enzyme - An Overview
Current Pharmaceutical Biotechnology, 2022Abstract: Cardiovascular diseases, like coronary heart disease or artery disorders (arteriosclerosis, including artery solidification), heart failure (myocardial infarction), arrhythmias, congestive heart condition, stroke, elevated vital signs (hypertension), rheumatic heart disorder, and other circulato-ry system dysfunctions are the most common ...
Devika Rengaswamy, Parveen Abdul Rahim
openaire +2 more sources
Fibrinokinase and Fibrinolytic Enzymes
Nature, 1948CONFUSION has arisen concerning the terminology of the fibrinolytic enzymes and pro-enzymes contained in blood plasma. In our papers on the fibrinolytic activator contained in tissue cells1,2, we adhered to the nomenclature used by Loomis, George and Ryder3, which is adequate from a biochemical point of view, and which has also been used recently by ...
T, ASTRUP, P M, PERMIN
openaire +2 more sources
Thrombin-E as a Fibrinolytic Enzyme
Science, 1960Thrombin-E has been produced in adequate quantity for pharmacological studies. After intravenous infusion in dogs there were no significant changes in blood pressure, temperature, pulse rate, and respiratory movements. There were drops in platelet and white cell count, and there was an increase in blood-sugar level. Powerful fibrinolytic phenomena were
W H, SEEGERS +2 more
openaire +2 more sources
The fibrinolytic enzyme system in the newborn
American Journal of Obstetrics and Gynecology, 1966Abstract 1. 1. In confirmation of previous reports the plasminogen level in cord blood is shown to be low and decreases further in the first days of life. 2. 2. Plasmin, urokinase, and streptokinase inhibitor levels are in the normal adult ranges. 3. 3. Activator is present in cord blood and is considered to be responsible for spontaneous
F, Beller, G W, Douglas, M D, Epstein
openaire +2 more sources
Thrombosis and Haemostasis, 1981
It has been known for seme time that plasma contains acid proteinases and that such enzymes are capable of the eventual digestion of fibrin under the conditions of the monochloroacetic acid assay for factor XIII action. It has also been suggested that the enzyme responsible is pepsin, present in the circulation as pepsinogen.
Nooshabeh Pejhan +2 more
openaire +1 more source
It has been known for seme time that plasma contains acid proteinases and that such enzymes are capable of the eventual digestion of fibrin under the conditions of the monochloroacetic acid assay for factor XIII action. It has also been suggested that the enzyme responsible is pepsin, present in the circulation as pepsinogen.
Nooshabeh Pejhan +2 more
openaire +1 more source
Fibrinolytic Enzymes for Thrombolytic Therapy
2019Cardiovascular diseases are a group of disorders consisting importantly of coronary heart disease, peripheral arterial disease, cerebrovascular disease, rheumatic heart disease, congenital heart disease, deep vein thrombosis and pulmonary embolism. Severe cardiovascular disease conditions lead to acute myocardial infarction and stroke.
Swaroop S, Kumar, Abdulhameed, Sabu
openaire +2 more sources
Patented Fibrinolytic Enzymes: An Overview
Recent Patents on BiotechnologyAbstract: Fibrinolytic enzymes have garnered significant attention from researchers due to their immense potential in the medical field. As research continues to advance, the outcomes have become increasingly fruitful. The generation of applicable knowledge is usually accompanied by its protection through patent
Yuan Cao +4 more
openaire +2 more sources
The Fibrinolytic Enzyme System in Malignant Lymphomas
Acta Haematologica, 2009Components of the fibrinolytic enzyme systern were measured in 40 patients with malignant lymphomas. Fibrinolytic activity, as assessed by the euglobulin clot lysis time, was reduced in the majority of patients. The mean fibrinogen level was elevated in patients with Hodgkin’s disease and reticulum cell sarcoma.
D, Ogston, A, Dawson
openaire +2 more sources